Latha Khary
About Latha Khary
Latha Khary serves as the Americas Head of Client Risk Rating at UBS, a position she has held since 2020. She holds a Master of Engineering from The City College of New York and an MBA in Pharmaceutical Management from Rutgers Business School, with prior experience at Meda Pharmaceuticals and Deloitte.
Work at UBS
Latha Khary has been serving as the Americas Head of Client Risk Rating at UBS since 2020. In this role, she is responsible for overseeing the risk assessment processes for clients across the Americas region. Her position involves analyzing client data and implementing strategies to enhance risk management practices. Khary's expertise contributes to the firm's efforts in maintaining compliance and optimizing client relationships.
Previous Experience at Deloitte
Before joining UBS, Latha Khary worked at Deloitte as a Senior Manager in Deloitte Advisory from 2011 to 2020. During her nine-year tenure, she focused on providing strategic advisory services to clients, helping them navigate complex business challenges. Her role involved leading teams and managing projects aimed at improving operational efficiency and risk management.
Role at Meda Pharmaceuticals
Latha Khary began her career in the pharmaceutical industry at Meda Pharmaceuticals, where she held the position of Manager of Sales Analytics & Market Research from 2006 to 2011. In this role, she was responsible for analyzing market trends and sales data to inform strategic decisions. Her work contributed to the company's understanding of market dynamics and consumer behavior.
Education and Expertise
Latha Khary holds a Master of Engineering (MEng) from The City College of New York. She also earned an MBA in Pharmaceutical Management from Rutgers Business School. Her educational background equips her with a strong foundation in engineering principles and business management, particularly within the pharmaceutical sector.